[Irinotecan monotherapy in the treatment of colorectal cancers: results of phase II trials]. [electronic resource]
Producer: 19990216Description: 33-7 p. digitalISSN:- 0007-4551
- Adenocarcinoma -- drug therapy
- Adult
- Aged
- Antimetabolites, Antineoplastic -- therapeutic use
- Antineoplastic Agents, Phytogenic -- adverse effects
- Camptothecin -- adverse effects
- Clinical Trials, Phase II as Topic
- Colorectal Neoplasms -- drug therapy
- Disease-Free Survival
- Drug Resistance, Neoplasm
- Enzyme Inhibitors -- adverse effects
- Europe
- Female
- Fluorouracil -- therapeutic use
- Humans
- Irinotecan
- Male
- Middle Aged
- Neoplasm Metastasis
- Neoplasm Proteins -- antagonists & inhibitors
- Palliative Care
- Remission Induction
- Salvage Therapy
- Topoisomerase I Inhibitors
- Treatment Outcome
- United States
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.